Literature DB >> 8699547

Compulsory supervision and methadone maintenance.

D P Desmond1, J F Maddux.   

Abstract

Treatment outcomes of 296 subjects admitted to methadone maintenance while on probation or parole are compared to those of 314 subjects admitted without such compulsory supervision. Equivalent treatment services were offered to both groups. The pretreatment differences between groups were small except for time incarcerated. All subjects were followed for one year. The compulsory supervision group had worse outcomes with respect to retention, productive activity, and incarceration. The differences were small except for incarceration. The mean number of months incarcerated was 2.1 for the compulsory supervision group and 0.7 for the voluntary group. Of subjects discharged from treatment, a higher percentage of the compulsory supervision group was discharged because of incarceration, but a higher percentage of the voluntary group was discharged for noncompliance with program requirements. The findings do not support a policy of exclusion of opioid users from methadone maintenance because they are on probation or parole.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699547     DOI: 10.1016/0740-5472(95)02024-1

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  7 in total

1.  Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Sharon M Kelly; Kevin E O'Grady; Jerome H Jaffe; Yngvild K Olsen; Robert P Schwartz
Journal:  J Drug Issues       Date:  2014-01

2.  Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon Gwin Mitchell; Jan Gryczynski; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2018-11-19

3.  Premature discharge from methadone treatment: patient perspectives.

Authors:  Heather Schacht Reisinger; Robert P Schwartz; Shannon Gwin Mitchell; James A Peterson; Sharon M Kelly; Kevin E O'Grady; Erica A Marrari; Barry S Brown; Michael H Agar
Journal:  J Psychoactive Drugs       Date:  2009-09

4.  Predictors of methadone treatment retention from a multi-site study: a survival analysis.

Authors:  Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2011-02-09       Impact factor: 4.492

5.  Pharmacotherapy for opioid addiction in community corrections.

Authors:  Robert P Schwartz; Mary M Mitchell; Kevin E O'Grady; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Michael S Gordon; Jerome H Jaffe
Journal:  Int Rev Psychiatry       Date:  2018-12-06

6.  Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.

Authors:  Sharon M Kelly; Kevin E Oʼgrady; Jerome H Jaffe; Devang Gandhi; Robert P Schwartz
Journal:  J Addict Med       Date:  2013 Mar-Apr       Impact factor: 3.702

7.  Buprenorphine Treatment for Probationers and Parolees.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kathryn A Couvillion; Laura J Sudec; Kevin E O'Grady; Frank J Vocci; Hamin Shabazz
Journal:  Subst Abus       Date:  2014-04-04       Impact factor: 3.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.